Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
MC2 Therapeutics
MC2 Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Wynzora
Betamethasone
,
Calcipotriene
2020-07-20
2027-2039
Psoriasis
,
Atopic dermatitis
,
Pruritus ani
,
Inflammation
,
Facial dermatoses
,
Seborrheic dermatitis
,
Foot dermatoses
,
Hand dermatoses
,
Scalp dermatoses
,
Leg dermatoses
,
Mycoses
,
Oral candidiasis
,
Vulvovaginal candidiasis
,
Tinea pedis
,
Cutaneous candidiasis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Betamethasone
psoriasis
Calcipotriene
psoriasis
Microcrystalline cellulose
carcinoma
,
ovarian neoplasms
,
serous cystadenocarcinoma
,
fallopian tube neoplasms
,
carcinosarcoma
,
hereditary breast and ovarian cancer syndrome
,
mullerian mixed tumor
,
recurrence
,
leukemia
,
myeloid leukemia acute
,
precursor cell lymphoblastic leukemia-lymphoma
,
myeloid leukemia
,
precursor t-cell lymphoblastic leukemia-lymphoma
,
acute disease
,
lymphoid leukemia
Corticoids
parkinson disease
,
alopecia areata
,
alopecia
,
atopic dermatitis
,
eczema
,
dermatitis
,
rheumatoid arthritis
,
arthritis
,
connective tissue diseases
,
autoimmune diseases
,
systemic lupus erythematosus
,
inborn genetic diseases
,
skin diseases
,
genetic skin diseases
,
sinusitis
,
nasal polyps
,
polyps
,
rhinosinusitis
,
allergic rhinitis
,
rhinitis
,
allergic rhinitis perennial
,
diabetes mellitus
,
osteoporosis
Daivonex
psoriasis
,
actinic keratosis
,
keratosis
Diprosone
carcinoma
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
lung neoplasms
,
folliculitis
,
psoriasis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use